CU23637B6 - TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES - Google Patents

TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES

Info

Publication number
CU23637B6
CU23637B6 CU20060204A CU20060204A CU23637B6 CU 23637 B6 CU23637 B6 CU 23637B6 CU 20060204 A CU20060204 A CU 20060204A CU 20060204 A CU20060204 A CU 20060204A CU 23637 B6 CU23637 B6 CU 23637B6
Authority
CU
Cuba
Prior art keywords
hemorragy
conceptive
regimes
disruption
treatment
Prior art date
Application number
CU20060204A
Other languages
Spanish (es)
Other versions
CU20060204A7 (en
Inventor
Andreas Sachse
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of CU20060204A7 publication Critical patent/CU20060204A7/en
Publication of CU23637B6 publication Critical patent/CU23637B6/en

Links

Abstract

La presente invención se relaciona con un uso de un régimen extendido flexible para la anticoncepción hormonal, útil para tratar problemas de hemorragias asociados con el uso extendido fijo de anticonceptivos hormonales y envase farmacéutico que contiene el respectivo anticonceptivo hormonal.The present invention relates to a use of a flexible extended regimen for hormonal contraception, useful for treating bleeding problems associated with the fixed extended use of hormonal contraceptives and pharmaceutical packaging containing the respective hormonal contraceptive.

CU20060204A 2004-04-30 2006-10-27 TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES CU23637B6 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US56644304P 2004-04-30 2004-04-30
US57502404P 2004-05-28 2004-05-28
US57719904P 2004-06-07 2004-06-07
US63838004P 2004-12-27 2004-12-27

Publications (2)

Publication Number Publication Date
CU20060204A7 CU20060204A7 (en) 2010-02-23
CU23637B6 true CU23637B6 (en) 2011-03-21

Family

ID=44280809

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20060204A CU23637B6 (en) 2004-04-30 2006-10-27 TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES

Country Status (1)

Country Link
CU (1) CU23637B6 (en)

Also Published As

Publication number Publication date
CU20060204A7 (en) 2010-02-23

Similar Documents

Publication Publication Date Title
UY28875A1 (en) TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES.
CY1120879T1 (en) MULTIPLE INGREDIENT BIOACTIVE INTALCALINE RING
ECSP088097A (en) NEW REGIMES FOR CONTROLLED DRUG ADMINISTRATION DEVICES FOR CONTRACEPTION
AR077199A1 (en) PHARMACEUTICAL COMPOSITION AND TREATMENT PROCEDURE FOR EMERGENCY ANTI-CONCEPTION
CL2007001724A1 (en) USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1
BRPI0501449A (en) Functional mixture, processes for curing and partially curing a functional mixture, and adhesive
AR061958A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID
MXPA06010767A (en) Anhydrous pharmaceutical composition associating a siliconated agent and solubilised active principle.
MX2009003992A (en) Package for disposable absorbent articles and kit of package and disposable absorbent article.
CL2007001961A1 (en) Pharmaceutical composition containing a) 2.0 mg of dienogest and 0.015 mg of ethinylestradiol and (6s) -5-methyl-tetrahydrofolate and one or more excipient / vehicles; kit; use for femeneine contraception and reduce the risk of congenital malformations due to lack of folate in pregnancy.
PE20211588A1 (en) COMPOUNDS AND THEIR USES TO RELIEVE SYMPTOMS ASSOCIATED WITH MENOPAUSE
PE20040068A1 (en) ETONOGESTREL DECANOATE, UNDECANOATE AND DODECANOATE
GT200500268A (en) INHIBITORS OF THE SOLUBLE CYCLING ADENYLATE
GB0507598D0 (en) Composition
DOP2006000257A (en) DERIVATIVES OF 9-CHLORINE-15-DEOXIPROSTAGLANDIN, PROCESSES FOR ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
CU23637B6 (en) TREATMENT OF DISRUPTION HEMORRAGY IN EXTENDED ANTI-CONCEPTIVE REGIMES
CL2008000999A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING DROSPIRENONE AND 17BETA ESTRADIOL; PHARMACEUTICAL KIT THAT INCLUDES SUCH COMPOSITION, USEFUL FOR HORMONAL THERAPY AND CONTRACEPTION IN WOMEN.
BRPI0513825A (en) epothilone combinations
PE20070555A1 (en) USE OF ESTRADIOL VALERATE IN COMBINATION WITH DIENOGEST FOR THE ORAL THERAPY OF DYSFUNCTIONAL UTERINE HEMORRHAGE CONNECTED WITH AN ORAL CONTRACEPTION
AR049195A1 (en) USE OF A COMBINATION OF ETHINYLESTRADIOL AND ACETATE OF CLORMADINONE FOR THE PREPARATION OF A MEDICINAL PRODUCT
CL2011000252A1 (en) Use of estriol to prepare a useful medication in the prevention and / or treatment of urogenital atrophy in women.
UA91190C2 (en) Management of breakthrough bleeding in extended hormonal contraceptive regimens
AR049220A1 (en) USE OF 7-TER-BUTOXIIMINOMETILCAMPTOTECINA IN THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF UTERINE NEOPLASMS
CL2008001147A1 (en) Pharmaceutical combination comprising 11b- (4-acetylphenyl) -17b-hydroxy-17 (1,1,2,2,2-pentafluoroethyl) estra-4,9-dien-3-one together with at least one pure non-steroidal antiestrogen ; and use for prophylaxis or treatment of brca1 or brca2 mediated cancer.
BR112019002550A2 (en) fabric closure device

Legal Events

Date Code Title Description
FG Grant of patent